record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to staterecord state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundtheoretical · manual state transition
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition
evidence type
theoretical
conditions
Provenance
source title
Pooled safety analysis across five clinical trials; compassionate use programs
authors
reviewer:will-blair
ONC201 is well-tolerated with only grade 1-2 adverse events reported; no grade 4 treatment-related AEs; most common grade 3 AE is fatigue (10%); safety profile supports use in pediatric populations age ≥1 year.
vs_95868c02be5b0684 · manual_curation
outgoing
No outgoing links.
incoming
events
vev_7978d8b6258c2938finding.assertedManual finding added to frontier state
reviewer:will-blair · 2026-05-29
reviewable changes
vpr_7d774947255eaba9finding.addManual finding added to frontier state
applied · reviewer:will-blair · 2026-05-29
evaluations
No evaluation record targets this finding id.